Sarah A Brill, DO
Family Practice · San Carlos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 2 carriers
- Offices
- 2
- Since medical school
- 15 years
- New York College of Osteo Medicine of New York Institute of Technology, 2011
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital · Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
16 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brill’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$21,577
Medicare paid this office $21,577 for 94 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 52 | $9,844 | $106 |
| Short return visit (20+ min) | 26 | $2,352 | $71 |
| Insertion of needle into vein for collection of blood sample | 40 | $441 | $9 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 18 | $403 | $14 |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
94 Original Medicare patients in 2024. Average age 74 · Women 61% · Health risk score 1.09. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 64% · Depression 27% · Diabetes 24% · Coronary heart disease 22% · Chronic kidney disease 19% · Atrial fibrillation 15% · Cancer 13% · COPD 13%.
The office billed $143,072, Medicare allowed $28,802 and paid $21,577; for 283 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 94 | 283 | 74 | 1.09 | $143,072 | $21,577 |
| 2023 | 68 | 144 | 74 | 0.81 | $73,672 | $11,161 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 30 | $4,609 | $112 |
| Short return visit (20+ min) | 20 | $1,633 | $78 |
| Insertion of needle into vein for collection of blood sample | 31 | $294 | $8 |
Drugs they prescribed that Part D paid
$82,700
Pharmacies billed $82,700 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (21 of 825) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
739 generic and fewer than 11 brand-name prescriptions · $82,700 in drug cost · 33 antibiotic prescriptions to 18 people · 16 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 16 | $27,733 | $1,733 |
| Levothyroxine | 29 | $490 | $17 |
| Gabapentin | 34 | $475 | $14 |
| Atorvastatin | 57 | $397 | $7 |
| Omeprazole | 25 | $186 | $7 |
See all 17 drugs
| Jardiance | 16 | $27,733 | $1,733 |
| Levothyroxine | 29 | $490 | $17 |
| Gabapentin | 34 | $475 | $14 |
| Atorvastatin | 57 | $397 | $7 |
| Omeprazole | 25 | $186 | $7 |
| Losartan | 25 | $173 | $7 |
| Albuterol Sulfate Hfa | 16 | $147 | $9 |
| Metformin Hcl Er | 13 | $111 | $9 |
| Baclofen | 11 | $89 | $8 |
| Lisinopril | 17 | $87 | $5 |
| Trazodone | 15 | $67 | $4 |
| Ibuprofen | 14 | $60 | $4 |
| Tramadol | 13 | $58 | $4 |
| Diazepam | 11 | $57 | $5 |
| Amlodipine Besylate | 19 | $54 | $3 |
| Hydrochlorothiazide | 11 | $36 | $3 |
| Metformin | 18 | $25 | $1 |
Year by year
| 2024 | 825 | 94 | 3% (21) | None | $82,700 |
| 2023 | 241 | 76 | None | 11% | $21,498 |
| 2022 | 764 | 197 | 0% (0) | 11% | $44,016 |
| 2021 | 3,768 | 394 | 5% (178) | 11% | $201,162 |
| 2020 | 4,021 | 441 | 6% (231) | 12% | $189,052 |
| 2019 | 3,754 | 464 | 5% (199) | 13% | $171,855 |
| 2018 | 3,753 | 549 | 6% (216) | 17% | $162,655 |
| 2017 | 3,355 | 382 | 7% (244) | 18% | $140,479 |
| 2016 | 1,720 | 266 | 9% (148) | 18% | $78,643 |
| 2015 | 308 | 75 | 6% (18) | None | $12,988 |
| 2014 | 34 | 11 | 0% (0) | None | $3,886 |
| 2013 | 48 | 20 | None | None | $1,543 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 21 drugs
| Gabapentin | 23 | $926 | $40 |
| Betamethasone Valerate | 14 | $808 | $58 |
| Atorvastatin | 44 | $703 | $16 |
| Losartan | 34 | $559 | $16 |
| Terazosin | 14 | $550 | $39 |
| Famotidine | 25 | $501 | $20 |
| Amlodipine Besylate | 38 | $478 | $13 |
| Lisinopril | 30 | $425 | $14 |
| Levothyroxine | 20 | $424 | $21 |
| Tamsulosin | 19 | $384 | $20 |
| Atenolol | 23 | $342 | $15 |
| Hydralazine | 17 | $329 | $19 |
| Furosemide | 21 | $325 | $15 |
| Sertraline | 13 | $272 | $21 |
| Omeprazole | 23 | $235 | $10 |
| Hydrochlorothiazide | 21 | $223 | $11 |
| Simvastatin | 17 | $192 | $11 |
| Fluticasone Propionate | 13 | $171 | $13 |
| Montelukast | 14 | $155 | $11 |
| Metformin Hcl Er | 13 | $118 | $9 |
| Carvedilol | 11 | $118 | $11 |
2021: 83 drugs
| Oxycontin | 23 | $20,271 | $881 |
| Spiriva Respimat | 15 | $8,793 | $586 |
| Pradaxa | 11 | $7,367 | $670 |
| Alvesco | 55 | $6,541 | $119 |
| Atorvastatin | 193 | $2,985 | $15 |
| Betamethasone Valerate | 53 | $2,792 | $53 |
| Gabapentin | 102 | $2,754 | $27 |
| Levothyroxine | 113 | $2,571 | $23 |
| Hydrocodone-Acetaminophen | 101 | $2,272 | $22 |
| Losartan | 131 | $1,825 | $14 |
| Famotidine | 153 | $1,689 | $11 |
| Amlodipine Besylate | 143 | $1,688 | $12 |
| Terazosin | 42 | $1,652 | $39 |
| Omeprazole | 78 | $1,485 | $19 |
| Diclofenac | 49 | $1,397 | $29 |
| Hydralazine | 43 | $1,367 | $32 |
| Atenolol | 126 | $1,366 | $11 |
| Lisinopril | 106 | $1,339 | $13 |
| Fluticasone Propionate | 94 | $1,240 | $13 |
| Furosemide | 82 | $1,168 | $14 |
| Tamsulosin | 44 | $1,018 | $23 |
| Isosorbide Mononitrate Er | 24 | $1,006 | $42 |
| Duloxetine | 28 | $997 | $36 |
| Bupropion Xl | 19 | $988 | $52 |
| Albuterol Sulfate Hfa | 47 | $929 | $20 |
| Simvastatin | 82 | $910 | $11 |
| Hydrochlorothiazide | 73 | $892 | $12 |
| Allopurinol | 28 | $816 | $29 |
| Oxybutynin Chloride Er | 19 | $804 | $42 |
| Trazodone | 34 | $797 | $23 |
| Donepezil | 20 | $787 | $39 |
| Pantoprazole | 30 | $783 | $26 |
| Ventolin Hfa | 14 | $778 | $56 |
| Pravastatin | 19 | $764 | $40 |
| Sucralfate | 12 | $754 | $63 |
| Metformin | 53 | $753 | $14 |
| Olanzapine | 16 | $748 | $47 |
| Diltiazem 24hr Er (Xr) | 14 | $734 | $52 |
| Metoprolol | 30 | $633 | $21 |
| Nabumetone | 11 | $625 | $57 |
| Sertraline | 30 | $611 | $20 |
| Klor-Con 8 | 12 | $598 | $50 |
| Lovastatin | 46 | $582 | $13 |
| Ibuprofen | 30 | $568 | $19 |
| Acyclovir | 13 | $550 | $42 |
| Glipizide Er | 13 | $539 | $41 |
| Nortriptyline | 16 | $528 | $33 |
| Dicyclomine | 12 | $520 | $43 |
| Digoxin | 17 | $497 | $29 |
| Ondansetron | 36 | $489 | $14 |
| Lidocaine | 12 | $472 | $39 |
| Metoprolol | 44 | $465 | $11 |
| Finasteride | 25 | $456 | $18 |
| Hydrocortisone | 40 | $437 | $11 |
| Doxycycline Monohydrate | 26 | $426 | $16 |
| Veo Insulin | 15 | $426 | $28 |
| Montelukast | 37 | $414 | $11 |
| Glipizide | 29 | $408 | $14 |
| Clopidogrel | 16 | $401 | $25 |
| Nitroglycerin | 12 | $399 | $33 |
| Lactulose | 18 | $391 | $22 |
| Alendronate | 34 | $354 | $10 |
| Lorazepam | 44 | $335 | $8 |
| Tizanidine | 18 | $328 | $18 |
| Quetiapine | 15 | $328 | $22 |
| K-Tab Er | 12 | $324 | $27 |
| Carvedilol | 20 | $298 | $15 |
| Lisinopril-Hydrochlorothiazide | 25 | $278 | $11 |
| Fluoxetine | 23 | $265 | $12 |
| Citalopram Hbr | 18 | $263 | $15 |
| Triamcinolone Acetonide | 19 | $210 | $11 |
| Meloxicam | 19 | $207 | $11 |
| Prednisone | 20 | $203 | $10 |
| Cefadroxil | 20 | $196 | $10 |
| Spironolactone | 18 | $193 | $11 |
| Buspirone | 20 | $178 | $9 |
| Tramadol | 21 | $165 | $8 |
| Metformin Hcl Er | 20 | $162 | $8 |
| Zolpidem | 22 | $152 | $7 |
| Hydroxyzine | 19 | $152 | $8 |
| Rosuvastatin | 11 | $146 | $13 |
| Cephalexin | 14 | $145 | $10 |
| Oxycodone-Acetaminophen | 12 | $142 | $12 |
2020: 83 drugs
| Oxycontin | 23 | $20,525 | $892 |
| Spiriva Respimat | 25 | $9,287 | $371 |
| Pradaxa | 12 | $7,674 | $639 |
| Advair Diskus | 31 | $6,085 | $196 |
| Gabapentin | 130 | $4,671 | $36 |
| Alvesco | 48 | $4,459 | $93 |
| Levothyroxine | 136 | $3,603 | $26 |
| Humulin N | 19 | $3,563 | $188 |
| Hydrocodone-Acetaminophen | 157 | $3,360 | $21 |
| Atorvastatin | 200 | $3,267 | $16 |
| Humulin 70-30 | 14 | $2,866 | $205 |
| Ventolin Hfa | 55 | $2,649 | $48 |
| Buspirone | 39 | $2,300 | $59 |
| Omeprazole | 93 | $2,192 | $24 |
| Losartan | 140 | $1,741 | $12 |
| Lisinopril | 124 | $1,572 | $13 |
| Terazosin | 49 | $1,513 | $31 |
| Amlodipine Besylate | 137 | $1,511 | $11 |
| Duloxetine | 40 | $1,472 | $37 |
| Tamsulosin | 60 | $1,273 | $21 |
| Famotidine | 130 | $1,210 | $9 |
| Hydralazine | 48 | $1,209 | $25 |
| Sucralfate | 17 | $1,181 | $69 |
| Furosemide | 82 | $1,170 | $14 |
| Bupropion Xl | 23 | $1,158 | $50 |
| Atenolol | 111 | $1,119 | $10 |
| Fluticasone Propionate | 78 | $1,047 | $13 |
| Simvastatin | 93 | $1,038 | $11 |
| Donepezil | 31 | $1,002 | $32 |
| Betamethasone Valerate | 17 | $904 | $53 |
| Allopurinol | 33 | $888 | $27 |
| Metformin | 76 | $863 | $11 |
| Sertraline | 44 | $836 | $19 |
| Trazodone | 42 | $760 | $18 |
| Dicyclomine | 17 | $743 | $44 |
| Hydrochlorothiazide | 68 | $738 | $11 |
| Doxycycline Monohydrate | 48 | $683 | $14 |
| Diclofenac | 21 | $677 | $32 |
| Metoprolol | 67 | $669 | $10 |
| Misoprostol | 13 | $663 | $51 |
| Lactulose | 25 | $581 | $23 |
| Olanzapine | 17 | $556 | $33 |
| Lovastatin | 43 | $541 | $13 |
| Pravastatin | 14 | $540 | $39 |
| Pantoprazole | 20 | $523 | $26 |
| Montelukast | 43 | $513 | $12 |
| K-Tab Er | 20 | $510 | $25 |
| Nortriptyline | 13 | $469 | $36 |
| Ibuprofen | 24 | $441 | $18 |
| Acyclovir | 18 | $439 | $24 |
| Oxybutynin Chloride Er | 19 | $438 | $23 |
| Isosorbide Mononitrate Er | 27 | $416 | $15 |
| Nitroglycerin | 15 | $413 | $28 |
| Clonidine | 19 | $387 | $20 |
| Hydrocortisone | 34 | $372 | $11 |
| Glipizide | 34 | $357 | $11 |
| Veo Insulin | 19 | $355 | $19 |
| Alendronate | 33 | $339 | $10 |
| Cefadroxil | 28 | $328 | $12 |
| Spironolactone | 28 | $324 | $12 |
| Clopidogrel | 12 | $291 | $24 |
| Prednisone | 28 | $290 | $10 |
| Lisinopril-Hydrochlorothiazide | 25 | $284 | $11 |
| Finasteride | 12 | $282 | $24 |
| Ondansetron | 22 | $268 | $12 |
| Lorazepam | 33 | $256 | $8 |
| Morphine Sulfate Er | 12 | $255 | $21 |
| Tizanidine | 18 | $251 | $14 |
| Metoprolol | 11 | $243 | $22 |
| Meloxicam | 27 | $232 | $9 |
| Digoxin | 11 | $212 | $19 |
| Carvedilol | 18 | $210 | $12 |
| Quetiapine | 14 | $197 | $14 |
| Amoxicillin | 19 | $190 | $10 |
| Latanoprost | 12 | $176 | $15 |
| Tramadol | 19 | $175 | $9 |
| Cephalexin | 16 | $157 | $10 |
| Mupirocin | 12 | $155 | $13 |
| Triamterene-Hydrochlorothiazid | 12 | $149 | $12 |
| Fluoxetine | 13 | $148 | $11 |
| Citalopram Hbr | 12 | $140 | $12 |
| Oxycodone | 11 | $124 | $11 |
| Sulfamethoxazole-Trimethoprim | 19 | $120 | $6 |
2019: 78 drugs
| Spiriva Respimat | 34 | $11,159 | $328 |
| Pradaxa | 12 | $7,443 | $620 |
| Advair Diskus | 27 | $7,309 | $271 |
| Humulin N | 24 | $4,855 | $202 |
| Ventolin Hfa | 82 | $4,548 | $55 |
| Atorvastatin | 183 | $4,382 | $24 |
| Alvesco | 40 | $3,685 | $92 |
| Gabapentin | 131 | $3,500 | $27 |
| Levothyroxine | 116 | $3,168 | $27 |
| Hydrocodone-Acetaminophen | 130 | $2,514 | $19 |
| Trospium Chloride Er | 16 | $2,505 | $157 |
| Omeprazole | 90 | $2,389 | $27 |
| Humulin 70-30 | 12 | $2,266 | $189 |
| Oxybutynin Chloride Er | 20 | $1,955 | $98 |
| Terazosin | 61 | $1,933 | $32 |
| Sucralfate | 21 | $1,909 | $91 |
| Lisinopril | 128 | $1,598 | $12 |
| Atenolol | 122 | $1,458 | $12 |
| Famotidine | 91 | $1,431 | $16 |
| Losartan | 104 | $1,401 | $13 |
| Qvar | 13 | $1,357 | $104 |
| Amlodipine Besylate | 127 | $1,321 | $10 |
| Dilt-Xr | 14 | $1,173 | $84 |
| Fluticasone Propionate | 81 | $1,098 | $14 |
| Diclofenac | 12 | $1,083 | $90 |
| Morphine Sulfate Er | 23 | $1,039 | $45 |
| Simvastatin | 88 | $1,030 | $12 |
| Furosemide | 74 | $985 | $13 |
| Duloxetine | 25 | $938 | $38 |
| Bupropion Xl | 24 | $905 | $38 |
| Donepezil | 21 | $880 | $42 |
| Allopurinol | 21 | $823 | $39 |
| Tamsulosin | 31 | $799 | $26 |
| Metformin | 71 | $782 | $11 |
| Lovastatin | 57 | $762 | $13 |
| Sertraline | 38 | $715 | $19 |
| Hydralazine | 32 | $680 | $21 |
| Trazodone | 52 | $627 | $12 |
| Hydrochlorothiazide | 57 | $625 | $11 |
| Pravastatin | 15 | $537 | $36 |
| Ibuprofen | 25 | $530 | $21 |
| Metoprolol | 51 | $515 | $10 |
| Montelukast | 35 | $507 | $14 |
| Nitroglycerin | 16 | $506 | $32 |
| Lorazepam | 61 | $469 | $8 |
| Olanzapine | 14 | $460 | $33 |
| Hydrocortisone | 38 | $415 | $11 |
| Fluoxetine | 30 | $409 | $14 |
| Glipizide | 37 | $388 | $10 |
| Prednisone | 34 | $381 | $11 |
| Alendronate | 36 | $378 | $10 |
| K-Tab Er | 12 | $375 | $31 |
| Acyclovir | 17 | $349 | $21 |
| Ranitidine | 12 | $346 | $29 |
| Spironolactone | 26 | $333 | $13 |
| Doxycycline Monohydrate | 29 | $327 | $11 |
| Ondansetron | 32 | $327 | $10 |
| Lisinopril-Hydrochlorothiazide | 29 | $314 | $11 |
| Clopidogrel | 12 | $302 | $25 |
| Latanoprost | 14 | $294 | $21 |
| Cefadroxil | 24 | $275 | $11 |
| Veo Insulin | 17 | $268 | $16 |
| Triamcinolone Acetonide | 13 | $267 | $21 |
| Clonidine | 21 | $234 | $11 |
| Pantoprazole | 11 | $228 | $21 |
| Meloxicam | 27 | $225 | $8 |
| Isosorbide Mononitrate Er | 16 | $213 | $13 |
| Carvedilol | 14 | $167 | $12 |
| Zolpidem | 16 | $160 | $10 |
| Ciprofloxacin | 21 | $151 | $7 |
| Azithromycin | 17 | $149 | $9 |
| Triamterene-Hydrochlorothiazid | 12 | $149 | $12 |
| Mupirocin | 11 | $142 | $13 |
| Amoxicillin | 16 | $142 | $9 |
| Pramipexole Dihydrochloride | 12 | $130 | $11 |
| Quetiapine | 12 | $117 | $10 |
| Tramadol | 11 | $111 | $10 |
| Sulfamethoxazole-Trimethoprim | 12 | $75 | $6 |
2018: 72 drugs
| Advair Diskus | 26 | $10,010 | $385 |
| Qvar | 59 | $6,614 | $112 |
| Spiriva Respimat | 23 | $6,295 | $274 |
| Humulin N | 38 | $4,856 | $128 |
| Atorvastatin | 175 | $4,737 | $27 |
| Ventolin Hfa | 83 | $4,532 | $55 |
| Gabapentin | 100 | $3,619 | $36 |
| Levothyroxine | 115 | $3,282 | $29 |
| Hydrocodone-Acetaminophen | 143 | $3,050 | $21 |
| Humulin 70-30 | 14 | $2,530 | $181 |
| Omeprazole | 90 | $2,417 | $27 |
| Betamethasone Valerate | 38 | $2,281 | $60 |
| Losartan | 104 | $1,918 | $18 |
| Lisinopril | 134 | $1,608 | $12 |
| Atenolol | 128 | $1,577 | $12 |
| Famotidine | 70 | $1,448 | $21 |
| Humulin R | 14 | $1,391 | $99 |
| Diclofenac | 18 | $1,371 | $76 |
| Terazosin | 48 | $1,323 | $28 |
| Morphine Sulfate Er | 30 | $1,210 | $40 |
| Simvastatin | 102 | $1,158 | $11 |
| Ibuprofen | 44 | $1,089 | $25 |
| Hydralazine | 22 | $1,021 | $46 |
| Amlodipine Besylate | 136 | $1,017 | $7 |
| Hydrochlorothiazide | 87 | $947 | $11 |
| Metformin | 82 | $934 | $11 |
| Lovastatin | 73 | $891 | $12 |
| Donepezil | 22 | $885 | $40 |
| Fluticasone Propionate | 68 | $875 | $13 |
| Allopurinol | 23 | $816 | $35 |
| Sertraline | 42 | $780 | $19 |
| Montelukast | 35 | $676 | $19 |
| Ondansetron | 51 | $664 | $13 |
| Alendronate | 50 | $632 | $13 |
| Oxybutynin Chloride Er | 14 | $609 | $44 |
| Tamsulosin | 23 | $607 | $26 |
| Duloxetine | 11 | $599 | $54 |
| Bupropion Xl | 14 | $593 | $42 |
| Prednisone | 36 | $592 | $16 |
| Glipizide | 44 | $584 | $13 |
| Furosemide | 42 | $530 | $13 |
| Clonidine | 12 | $491 | $41 |
| Oxycodone-Acetaminophen | 13 | $486 | $37 |
| Olanzapine | 13 | $484 | $37 |
| Warfarin | 22 | $474 | $22 |
| Triamcinolone Acetonide | 13 | $432 | $33 |
| Lisinopril-Hydrochlorothiazide | 37 | $420 | $11 |
| Metoprolol | 43 | $419 | $10 |
| Veo Insulin | 28 | $410 | $15 |
| Lorazepam | 57 | $399 | $7 |
| Spironolactone | 35 | $394 | $11 |
| Ranitidine | 11 | $386 | $35 |
| Cefadroxil | 32 | $384 | $12 |
| Bupropion Hcl Sr | 11 | $375 | $34 |
| Trazodone | 29 | $374 | $13 |
| Fluoxetine | 29 | $362 | $12 |
| Betamethasone Diprop Augmented | 13 | $329 | $25 |
| Quetiapine | 17 | $323 | $19 |
| K-Tab Er | 12 | $311 | $26 |
| Hydrocortisone | 27 | $294 | $11 |
| Amoxicillin | 29 | $264 | $9 |
| Ketoconazole | 11 | $262 | $24 |
| Isosorbide Mononitrate Er | 18 | $239 | $13 |
| Zolpidem | 22 | $220 | $10 |
| Doxycycline Monohydrate | 19 | $218 | $11 |
| Meloxicam | 20 | $199 | $10 |
| Citalopram Hbr | 16 | $184 | $11 |
| Veo Insulin | 11 | $176 | $16 |
| Paroxetine | 12 | $168 | $14 |
| Carvedilol | 11 | $138 | $13 |
| Sulfamethoxazole-Trimethoprim | 19 | $118 | $6 |
| Ciprofloxacin | 12 | $80 | $7 |
2017: 71 drugs
| Spiriva Respimat | 24 | $5,661 | $236 |
| Hydrocodone-Acetaminophen | 155 | $5,427 | $35 |
| Qvar | 43 | $4,322 | $101 |
| Atorvastatin | 138 | $4,184 | $30 |
| Levothyroxine | 126 | $3,853 | $31 |
| Ventolin Hfa | 74 | $3,836 | $52 |
| Humulin N | 26 | $3,493 | $134 |
| Fluocinonide | 27 | $2,804 | $104 |
| Omeprazole | 92 | $2,781 | $30 |
| Gabapentin | 78 | $2,672 | $34 |
| Tacrolimus | 12 | $2,573 | $214 |
| Betamethasone Valerate | 27 | $1,841 | $68 |
| Lisinopril | 159 | $1,807 | $11 |
| Losartan | 68 | $1,720 | $25 |
| Humulin 70-30 | 16 | $1,688 | $105 |
| Famotidine | 64 | $1,631 | $25 |
| Morphine Sulfate Er | 32 | $1,533 | $48 |
| Atenolol | 117 | $1,422 | $12 |
| Bupropion Xl | 22 | $1,325 | $60 |
| Simvastatin | 104 | $1,245 | $12 |
| Oxybutynin Chloride Er | 22 | $1,223 | $56 |
| Sertraline | 54 | $1,138 | $21 |
| Ibuprofen | 43 | $1,136 | $26 |
| Klor-Con M20 | 16 | $960 | $60 |
| Dilt-Xr | 18 | $940 | $52 |
| Oxycodone | 20 | $931 | $47 |
| Allopurinol | 23 | $918 | $40 |
| Donepezil | 20 | $890 | $44 |
| Betamethasone Dipropionate | 11 | $855 | $78 |
| Diclofenac | 11 | $774 | $70 |
| Metformin | 63 | $724 | $11 |
| Furosemide | 62 | $724 | $12 |
| Amlodipine Besylate | 96 | $723 | $8 |
| Digoxin | 16 | $700 | $44 |
| Hydrochlorothiazide | 65 | $693 | $11 |
| Fluticasone Propionate | 53 | $692 | $13 |
| Warfarin | 56 | $621 | $11 |
| Nortriptyline | 27 | $620 | $23 |
| Tamsulosin | 21 | $615 | $29 |
| Glipizide | 40 | $580 | $15 |
| Lovastatin | 46 | $563 | $12 |
| Metoprolol | 54 | $493 | $9 |
| Prednisone | 23 | $475 | $21 |
| Spironolactone | 32 | $474 | $15 |
| Montelukast | 18 | $457 | $25 |
| Lorazepam | 55 | $447 | $8 |
| Nitroglycerin | 14 | $421 | $30 |
| Alendronate | 29 | $412 | $14 |
| Terazosin | 33 | $404 | $12 |
| Doxycycline Monohydrate | 37 | $404 | $11 |
| Ranitidine | 13 | $370 | $28 |
| Trazodone | 29 | $339 | $12 |
| Lisinopril-Hydrochlorothiazide | 28 | $320 | $11 |
| Quetiapine | 21 | $286 | $14 |
| Clonidine | 16 | $279 | $17 |
| Acetaminophen-Codeine | 11 | $278 | $25 |
| K-Tab Er | 12 | $265 | $22 |
| Baclofen | 11 | $260 | $24 |
| Ondansetron | 15 | $215 | $14 |
| Insulin | 13 | $193 | $15 |
| Hydrocortisone | 15 | $188 | $13 |
| Insulin | 15 | $183 | $12 |
| Triamterene-Hydrochlorothiazid | 12 | $176 | $15 |
| Pramipexole Dihydrochloride | 13 | $174 | $13 |
| Zolpidem | 15 | $143 | $10 |
| Citalopram Hbr | 13 | $139 | $11 |
| Amoxicillin | 15 | $135 | $9 |
| Cephalexin | 15 | $132 | $9 |
| Clonazepam | 12 | $123 | $10 |
| Fluoxetine | 11 | $120 | $11 |
| Sulfamethoxazole-Trimethoprim | 12 | $108 | $9 |
2016: 45 drugs
| Hydrocodone-Acetaminophen | 103 | $4,520 | $44 |
| Dulera | 12 | $2,874 | $240 |
| Omeprazole | 61 | $2,278 | $37 |
| Levothyroxine | 70 | $2,141 | $31 |
| Atorvastatin | 65 | $2,136 | $33 |
| Gabapentin | 41 | $1,916 | $47 |
| Losartan | 34 | $1,192 | $35 |
| Qvar | 12 | $1,069 | $89 |
| Ventolin Hfa | 22 | $928 | $42 |
| Famotidine | 31 | $915 | $30 |
| Oxycodone | 18 | $753 | $42 |
| Simvastatin | 44 | $743 | $17 |
| Amlodipine Besylate | 58 | $694 | $12 |
| Sertraline | 31 | $679 | $22 |
| Atenolol | 53 | $647 | $12 |
| Lisinopril | 55 | $641 | $12 |
| Triamcinolone Acetonide | 13 | $605 | $47 |
| Ibuprofen | 23 | $557 | $24 |
| Clopidogrel | 13 | $504 | $39 |
| Spironolactone | 12 | $418 | $35 |
| Furosemide | 38 | $395 | $10 |
| Nortriptyline | 13 | $373 | $29 |
| Warfarin | 34 | $355 | $10 |
| Fluticasone Propionate | 26 | $355 | $14 |
| K-Tab Er | 17 | $336 | $20 |
| Metformin | 28 | $318 | $11 |
| Glipizide | 22 | $312 | $14 |
| Prednisone | 15 | $306 | $20 |
| Metoprolol | 34 | $299 | $9 |
| Lovastatin | 21 | $289 | $14 |
| Ranitidine | 11 | $236 | $21 |
| Trazodone | 20 | $234 | $12 |
| Quetiapine | 15 | $232 | $15 |
| Pramipexole Dihydrochloride | 15 | $210 | $14 |
| Hydrocortisone | 17 | $208 | $12 |
| Naproxen | 12 | $202 | $17 |
| Lorazepam | 21 | $193 | $9 |
| Triamterene-Hydrochlorothiazid | 13 | $189 | $15 |
| Hydrochlorothiazide | 18 | $188 | $10 |
| Doxycycline Monohydrate | 13 | $183 | $14 |
| Baclofen | 11 | $175 | $16 |
| Zolpidem | 18 | $169 | $9 |
| Lisinopril-Hydrochlorothiazide | 13 | $142 | $11 |
| Azithromycin | 12 | $128 | $11 |
| Ciprofloxacin | 14 | $122 | $9 |
2015: 3 drugs
| Hydrocodone-Acetaminophen | 13 | $322 | $25 |
| Atorvastatin | 11 | $295 | $27 |
| Metformin | 11 | $101 | $9 |
Money from drug and device companies
$72 in 2025
A payment is not proof that care is biased.
| Gilead Sciences | None | $72 | 3 payments
|
See all 3 published payments
| Gilead Sciences | Meals · 2025-11-24 | None | $24 |
| Gilead Sciences | Meals · 2025-08-14 | None | $18 |
| Gilead Sciences | Meals · 2025-07-23 | None | $29 |
Professional record
- NPI
- 1861787236
- Licence
- NY 20A13935
- Trained
- New York College of Osteo Medicine of New York Institute of Technology, 2011 · 15 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2011-06-14
- NPI last updated
- 2026-07-10
- NPI record certified
- 2026-07-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 35 Shrubland Rd Apt 16, Southampton, NY, 11968